Biocon Ltd. — Regulatory Filings 2021

Sep 30, 2021

==> picture [102 x 40] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

September 30, 2021

To The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
September 29,2021	Myriad Asset Management HK	Teleconference	Bangalore
September 29,2021	Quantum Advisors	Teleconference	Bangalore
September 29,2021	Millennium	Teleconference	Bangalore
September 29,2021	Federal Reserve Bank NY	Teleconference	Bangalore
September 29,2021	Tata Mutual Fund	Teleconference	Bangalore
September 29,2021	DICO	Teleconference	Bangalore
September 29,2021	L&T Investment Management	Teleconference	Bangalore
September 29,2021	Fullerton Fund Management CompanyLtd	Teleconference	Bangalore
September 29,2021	HSBC Global AM HK	Teleconference	Bangalore
September 29,2021	Orbimed Advisors LLC	Teleconference	Bangalore
September 29,2021	Habrok Capital	Teleconference	Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [72 x 32] intentionally omitted <==

==> picture [73 x 76] intentionally omitted <==

---

Mayank Verma

Company Secretary and Compliance Officer